Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review (Q37869621)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 April 2011

Language	Label	Description	Also known as
English	Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review	scientific article published on 27 April 2011

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review (English)

1 reference

Europe PubMed Central

24 August 2017

1 reference

based on heuristic

inferred from title

author name string

Julio A S Koneski

1

1 reference

Europe PubMed Central

24 August 2017

Erasmo B Casella

2

1 reference

Europe PubMed Central

24 August 2017

Fábio Agertt

3

1 reference

Europe PubMed Central

24 August 2017

Maria Gabriela Ferreira

4

1 reference

Europe PubMed Central

24 August 2017

publication date

27 April 2011

1 reference

Europe PubMed Central

24 August 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

24 August 2017

21

1 reference

Europe PubMed Central

24 August 2017

3

1 reference

Europe PubMed Central

24 August 2017

228-232

1 reference

Europe PubMed Central

24 August 2017

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

The comorbidity of ADHD in the general population of Swedish school-age children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Psychopathology in children and adolescents with epilepsy: an investigation of predictive variables.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Understanding co-morbidities affecting children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Neurological comorbidity and epilepsy: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Epilepsy in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

ADHD drugs and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Mental health problems in children and adolescents referred to a national epilepsy center.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attentional Ability in Children with Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Cognitive and magnetic resonance volumetric abnormalities in new-onset pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention deficit disorder and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention deficit hyperactivity disorder in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Optimizing therapy of seizures in children and adolescents with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Childhood epilepsy, attention problems, and ADHD: review and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

ADHD as a risk factor for incident unprovoked seizures and epilepsy in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Decreased fractional anisotropy in the middle cerebellar peduncle in children with epilepsy and/or attention deficit/hyperactivity disorder: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Effects of seizures on developmental processes in the immature brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Effects of psychotropic drugs on seizure threshold

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Stimulant therapy and seizure risk in children with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Pharmacological management of a youth with ADHD and a seizure disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

The use of psychotropic drugs in epilepsy: what every neurologist should know

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Components of attention in children with complex partial seizures with and without ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

An Evaluation of the Effects of Methylphenidate on Outcomes in Adult Epilepsy Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Diagnostic performance of the CBCL-Attention Problem Scale as a screening measure in a sample of Brazilian children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Methylphenidate treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

A playroom observation procedure to assess children with mental retardation and ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Is ADHD a valid disorder in children with intellectual delays?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Psychiatric comorbidity in children with new onset epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.02.029

7 January 2021

Identifiers

10.1016/J.YEBEH.2011.02.029

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37869621&oldid=1751587595"